Nectar Lifesciences Ltd - 532649 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Nectar Lifesciences Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Nectar Lifesciences Ltd - 532649 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Nectar Lifesciences Limited has submitted the Exchange a copy Scrutinizers report and outcome of Annual General Meeting held on September 21, 2021. (Searchable Format) NECTAR LIFESCIENCES LTD. - 532649 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Nectar Lifesciences Limited has submitted the Exchange a copy Scrutinizers report and outcome of Annual General Meeting held on September 21, 2021. Nectar Lifesciences Ltd - 532649 - Proceedings Of 26Th Annual General Meeting Of The Company
Pursuant to regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find enclosed herewith proceedings of Annual General Meeting held on September 21, 2021. This is for your information and records please. Nectar Lifesciences Ltd - 532649 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We are furnishing herewith newspaper publication under the provisions of Section 91, 96 and 108 of the Companies Act, 2013 read with Companies (Management and Administration) Rules, 2014, in respect of Notice of Annual General Meeting, book closure and E-voting instructions, which have been published in the following newspapers: 1. Business Standard (English-all editions) dated 27.08.2021 2. Desh Sewak (Punjabi) dated 27.08.2021 NECTAR LIFESCIENCES LTD. - 532649 - Reg. 34 (1) Annual Report
Pursuant to regulations 30 and 34 of SEBI (Listing Obligations and Disclosures Requirement) Regulations 2015, please find enclosed herewith Annual Report for the financial year 2020-21. NECTAR LIFESCIENCES LTD. - 532649 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We are furnishing herewith newspaper copy of Publication of Financial Results of the Company for the quarter ended on June 30, 2021, which have been published in the following newspapers: 1. Financial Express (English-all editions) dated 15.08.2021 2. Desh Sewak (Punjabi) dated 15.08.2021 NECTAR LIFESCIENCES LTD. - 532649 - Board Meeting Outcome for Board Proposed To Appoint An Independent Director.
NECLIFE : Nectar Lifesciences Limited has informed the Exchange regarding Board meeting held on August 14, 2021 in which it is, inter alia, it has been decided to propose to members to appoint Dr. Kuldip Kumar Bhasin (DIN 0009250008) on the Board as an Independent Director of the company in the forthcoming Annual General Meeting to be held on September 21, 2021 ('AGM'). His term will be of five years in case he gets appointed in the AGM. The relevant disclosures in this regard are attached. Nectar Lifesciences Ltd - 532649 - Financial Results For The Quarter Ended On June 30, 2021
Limited reviewed Unaudited Standalone & Consolidated Financial results for the quarter ended on June 30, 2021, which are enclosed herewith along with the Limited Review Reports of the Auditors thereon. NECTAR LIFESCIENCES LTD. - 532649 - Board Meeting Intimation for Financial Results For Quarter Ended On June, 2021
NECTAR LIFESCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2021 ,inter alia, to consider and approve Pursuant to Regulations 29, 30, 33 and other applicable Regulations of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the company will be held on Saturday, August 14, 2021 to consider and approve, inter alia amongst items, the Unaudited Financial Results for the quarter ended on June 30, 2021.